A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke (OCEANIC-AF)
研究单位：[1]Bayer[2]Beijing Tongren Hospital,Capital Medical University[3]Peking Union Medical College Hospital CAMS[4]Beijing Tsinghua Changgung Hospital[5]Zhongshan Hospital,Fudan University[6]Huashan Hospital,Fudan University
研究目的：
Researchers are looking for a better way to treat people with atrial fibrillation and prevent stroke or systemic embolism (blood clots travelling through the blood stream to plug another vessel).
